FDA Center for Tobacco Products
What is the Food and Drug Administration Center for Tobacco Products?
President Obama signed the Family Smoking Prevention and Tobacco Control Act (also called the "Tobacco Control Act") into law in June 2009, which led to the establishment of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).
This means that the FDA now has the authority to regulate tobacco products, which may significantly impact labeling and marketing of tobacco products aimed at children and youth.
Several parts of this Act take time to enforce, but a few rules have already been put into practice. See the timeline for the Act. Utilize this tool to make the Tobacco Control Act easier to access, understand, search, and use.
The American Academy of Pediatrics (AAP) Julius B. Richmond Center of Excellence has been involved in FDA CTP activities, including the activities below:
- FDA Tobacco Products Scientific Advisory Committee Meeting Open Public Hearings
- July 22, 2011: AAP Richmond Center Principal Investigator Dr. Jonathan Winickoff gave testimony about dissolvable tobacco products. Read Dr. Winickoff's testimony.
- November 18, 2010: AAP Richmond Center Principal Investigator Dr. Jonathan Winickoff gave testimony about menthol cigarettes. View the video or presentation slides.
- March 31, 2010: AAP Richmond Center Principal Investigator Dr. Susanne Tanski gave testimony about protecting children from the harms of tobacco. Read Dr. Tanski's testimony.
- Signing of Tobacco Control Act
- FDA bans flavored cigarettes
- Support for cigarette pack warning labels
Major Tobacco Control Act Milestones
- FDA reveals new cigarette pack warning labels
- FDA makes recommendations on the health impact of menthol cigarettes
- FDA bans low, light, and mild cigarettes
- Smokeless tobacco products must include warning labels